After A 4.06% Gain In Share Price, Is BriaCell Therapeutics Corp. (NASDAQ:BCTX) A Better Trade Than Others? – Marketing Sentinel
Home  »  Technologies   »  After A 4.06% Gain In Share Price, Is BriaCell The...

After A 4.06% Gain In Share Price, Is BriaCell Therapeutics Corp. (NASDAQ:BCTX) A Better Trade Than Others?

In last trading session, BriaCell Therapeutics Corp. (NASDAQ:BCTX) saw 0.65 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $8.45 trading at $0.33 or 4.06% at ring of the bell on the day assigns it a market valuation of $134.46M. That closing price of BCTX’s stock is at a discount of -47.57% from its 52-week high price of $12.47 and is indicating a premium of 66.75% from its 52-week low price of $2.81. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.56 million shares which gives us an average trading volume of 1.45 million if we extend that period to 3-months.

BriaCell Therapeutics Corp. (NASDAQ:BCTX) trade information

Upright in the green during last session for gaining 4.06%, in the last five days BCTX remained trading in the red while hitting it’s week-highest on Friday, 01/14/22 when the stock touched $8.45 price level, subtracting 0.0% to its value on the day. BriaCell Therapeutics Corp.’s shares saw a change of 2.05% in year-to-date performance and have moved -0.24% in past 5-day. BriaCell Therapeutics Corp. (NASDAQ:BCTX) showed a performance of 5.76% in past 30-days. Number of shares sold short was 1.73 million shares which calculate 0.76 days to cover the short interests.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


BriaCell Therapeutics Corp. (BCTX) estimates and forecasts

Statistics highlight that BriaCell Therapeutics Corp. is scoring comparatively lower than the scores of other players of the relevant industry. The company added 87.36% of value to its shares in past 6 months, showing an annual growth rate of -788.89% while that of industry is 7.90. Apart from that, the company came lowering its revenue forecast for fiscal year 2022.

BCTX Dividends

BriaCell Therapeutics Corp. is more likely to be releasing its next quarterly report in February and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

BriaCell Therapeutics Corp. (NASDAQ:BCTX)’s Major holders

Insiders are in possession of 25.81% of company’s total shares while institution are holding 26.65 percent of that, with stock having share float percentage of 35.92%. Investors also watch the number of corporate investors in a company very closely, which is 26.65% institutions for BriaCell Therapeutics Corp. that are currently holding shares of the company. Voloridge Investment Management, LLC is the top institutional holder at BCTX for having 0.16 million shares of worth $1.27 million. And as of Sep 29, 2021, it was holding 0.98% of the company’s outstanding shares.

The second largest institutional holder is Redmond Asset Management, LLC, which was holding about 0.14 million shares on Sep 29, 2021. The number of shares represents firm’s hold over 0.86% of outstanding shares, having a total worth of $1.11 million.

>> 7 Top Picks for the Post-Pandemic Economy <<

On the other hand, Fidelity NASDAQ Composite Index Fund and Collaborative Inv Ser Tr-FOMO ETF are the top two Mutual Funds which own company’s shares. As of Oct 30, 2021, the former fund manager was holding 32089.0 shares of worth $0.26 million or 0.20% of the total outstanding shares. The later fund manager was in possession of 4039.0 shares on Sep 29, 2021, making its stake of worth around $32715.0 in the company or a holder of 0.03% of company’s stock.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts



Download Free eBook For



100% free. stop anytime no spam